drugset / Trial / NCT07433179

A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

NCT07433179 ↗

Phase 1 Recruiting 150 enrolled Septerna, Inc.
RandomizedSequentialTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.

Timeline

Start
2026-03-04
Primary completion
2027-02
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject SEP-479 Unknown — Oral

Indications

No indication recorded.